Yumanity Therapeutics, Inc. (YMTX) Stock Analysis
DELISTED 2022
What happened to Yumanity Therapeutics, Inc. (YMTX) stock?
Yumanity Therapeutics, Inc. (YMTX) no longer trades on public markets. It was delisted in December 2022. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2022
- Last recorded price (historical):
- $1.89 (last quote on record before the December 2022 delisting; historical, not a current quote)
Market cap $15.7M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Yumanity Therapeutics, Inc. (YMTX). Yumanity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative diseases caused by protein misfolding. Their lead program, YTX-7739, is in Phase I clinical trials for Parkinson's disease.
Last analyzed: Mar 18, 2026Dated analysis: the newest financial statements on file are 19 months old (Mar 1, 2025), so the figures and score below describe that period, not today.
Yumanity Therapeutics, Inc. (YMTX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy YMTX shares?
No. YMTX stopped trading on public markets in December 2022, so the shares are not available through a broker. Anything you see quoted for YMTX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before YMTX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Yumanity Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.